NCT07519564 2026-04-09A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor CachexiaKexing Biopharm Co., Ltd.Phase 1 Not yet recruiting18 enrolled